Related Experiment Video
Updated: Feb 8, 2026

Driving Under the Influence: How Music Listening Affects Driving Behaviors
Published on: March 27, 2019
Immunity drives TET1 regulation in cancer through NF-κB
Evelyne Collignon1, Annalisa Canale2, Clémence Al Wardi1
1Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB (Université libre de Bruxelles)-Cancer Research Center (U-CRC), ULB, Brussels, Belgium.
Abstract:
Ten-eleven translocation enzymes (TET1, TET2, and TET3), which induce DNA demethylation and gene regulation by converting 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), are often down-regulated in cancer. We uncover, in basal-like breast cancer (BLBC), genome-wide 5hmC changes related to TET1 regulation. We further demonstrate that TET1 repression is associated with high expression of immune markers and high infiltration by immune cells. We identify in BLBC tissues an anticorrelation between TET1 expression and the major immunoregulator family nuclear factor κB (NF-κB). In vitro and in mice, TET1 is down-regulated in breast cancer cells upon NF-κB activation through binding of p65 to its consensus sequence in the TET1 promoter. We lastly show that these findings extend to other cancer types, including melanoma, lung, and thyroid cancers. Together, our data suggest a novel mode of regulation for TET1 in cancer and highlight a new paradigm in which the immune system can influence cancer cell epigenetics.
Insights
Ten-eleven translocation (TET) enzymes are crucial for DNA demethylation and gene regulation but are often down-regulated in cancer. This study reveals that the nuclear factor κB (NF-κB) pathway represses TET1 in breast cancer, impacting immune responses.
Area of Science:
- Epigenetics
- Cancer Biology
- Immunology
Background:
- Ten-eleven translocation (TET) enzymes (TET1, TET2, TET3) regulate gene expression via DNA demethylation, converting 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC).
- TET enzyme down-regulation is a common event in various cancers, suggesting a role in tumorigenesis.
- Basal-like breast cancer (BLBC) is an aggressive subtype with distinct molecular features.
Purpose of the Study:
- To investigate the role of TET1 in basal-like breast cancer (BLBC).
- To explore the relationship between TET1 expression, immune markers, and immune cell infiltration in BLBC.
- To elucidate the regulatory mechanisms controlling TET1 expression in cancer, particularly the involvement of the nuclear factor κB (NF-κB) pathway.
Main Methods:
- Genome-wide analysis of 5-hydroxymethylcytosine (5hmC) modifications in BLBC.
- Correlation analysis between TET1 expression and immune markers/cell infiltration.
- In vitro and in vivo studies using breast cancer cell lines and mouse models.
- Chromatin immunoprecipitation (ChIP) to assess p65 binding to the TET1 promoter.
Main Results:
- Genome-wide 5hmC changes were observed in BLBC, linked to TET1 regulation.
- TET1 repression was associated with increased expression of immune markers and higher immune cell infiltration.
- An inverse correlation was found between TET1 expression and nuclear factor κB (NF-κB) activity in BLBC tissues.
- NF-κB activation, via p65 binding to the TET1 promoter, led to TET1 down-regulation in breast cancer cells (in vitro and in mice).
- These regulatory patterns were also observed in melanoma, lung, and thyroid cancers.
Conclusions:
- The study identifies a novel mechanism of TET1 regulation in cancer, driven by the NF-κB pathway.
- NF-κB-mediated repression of TET1 influences the tumor immune microenvironment.
- This work highlights a new paradigm where immune signaling pathways can epigenetically modulate cancer cells.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
What is the Immune System?
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Epigenetic Regulation
GTPases and their Regulation
Large G-proteins,...

